Nonrandom cytogenetic changes in human acute leukemia and their clinical implicationsOHYASHIKI, K.Cancer genetics and cytogenetics. 1984, Vol 11, Num 4, pp 453-471, issn 0165-4608Article

Reply to: The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. by Kremer M et alOHYASHIKI, K; OHYASHIKI, J. H.Leukemia. 2006, Vol 20, Num 7, pp 1297-1298, issn 0887-6924, 2 p.Article

VARIANT PH¹ TRANSLOCATIONS IN CML AND THEIR INCIDENCE, INCLUDING TWO CASES WITH SEQUENTIAL LYMPHOID AND MYELOID CRISESOSHIMURA M; OHYASHIKI K; TERADA H et al.1982; CANCER GENET. CYTOGENET.; ISSN 0165-4608; NLD; DA. 1982; VOL. 5; NO 3; PP. 187-201; BIBL. 32 REF.Article

CYTOGENETIC AND HEMATOLOGIC FINDINGS IN ACUTE MYELOGENOUS LEUKEMIA, M2 ACCORDING TO THE FAB CLASSIFICATIONOSHIMURA M; OHYASHIKI K; MORI M et al.1982; GANN; ISSN 0016-450X; JPN; DA. 1982; VOL. 73; NO 2; PP. 212-216; BIBL. 14 REF.Article

A 14Q+ CHROMOSOME IN A MALIGNANT LYMPHOMA IN A PATIENT WITH DOWN'S SYNDROMEOSHIMURA M; OHYASHIKI K; TONOMURA A et al.1981; CANCER GENET. CYTOGENET.; ISSN 0165-4608; NLD; DA. 1981; VOL. 4; NO 3; PP. 247-250; BIBL. 21 REF.Article

CHRONIC MYELOGENOUS LEUKEMIA WITH TRANSLOCATIONS (3Q-; 9Q+) AND (17Q-; 22Q+). POSSIBLE CRUCIAL CYTOGENETIC EVENTS IN THE GENESES OF CMLOSHIMURA M; OHYASHIKI K; VEHARA M et al.1981; HUM. GENET.; ISSN 0340-6717; DEU; DA. 1981; VOL. 57; NO 1; PP. 48-51; BIBL. 21 REF.Article

The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cellsTAUCHI, T; OKABE, S; MIYAZAWA, K et al.International journal of oncology. 1998, Vol 12, Num 6, pp 1269-1276, issn 1019-6439Article

Neutrophil secondary-granule deficiency as a Hallmark of all-Trans retinoic acid-induced differentiation of acute promyelocytic leukemia cellsMIYAUCHI, J; OHYASHIKI, K; INATOMI, Y et al.Blood. 1997, Vol 90, Num 2, pp 803-813, issn 0006-4971Article

Homeobox genes in hematopoiesis and leukemogenesisSHIMAMOTO, T; OHYASHIKI, K; TOYAMA, K et al.International journal of hematology. 1998, Vol 67, Num 4, pp 339-350, issn 0925-5710Article

Medium pH determines the differentiation of human promyelocytic leukemia cells to basophils or easinophils by culturing in a protein- and serum-free mediumMUROI, K; SASAKI, R; MIURA, Y et al.Leukemia research. 1989, Vol 13, Num 2, pp 157-163, issn 0145-2126Article

Analysis of DNA from cells fixed in Carnoy's solution for cytogenetic studyOHYASHIKI, J. H; OHYASHIKI, K; TOYAMA, K et al.Cancer genetics and cytogenetics. 1988, Vol 34, Num 2, pp 159-163, issn 0165-4608Article

Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cellsOHYASHIKI, K; OHYASHIKI, J. H; SANDBERG, A. A et al.Cancer research (Baltimore). 1986, Vol 46, Num 7, pp 3642-3647, issn 0008-5472Article

H1f, a novel hepatic bZIP protein, shows alered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemiaHUNGER, S. P; OHYASHIKI, K; TOYAMA, K et al.Genes & development. 1992, Vol 6, Num 9, pp 1608-1620, issn 0890-9369Article

Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patientsOHYASHIKI, K.Clinical infectious diseases. 2004, Vol 39, pp S56-S58, issn 1058-4838, SUP1Conference Paper

Morphologic changes of neutrophils in myelodysplastic syndrome treated with recombinant human granulocyte colony-stimulating factorTOYAMA, K; OHYASHIKI, K; OHYASHIKI, J. H et al.Japanese journal of cancer research. 1988, Vol 79, Num 7, pp 813-816, issn 0910-5050Article

Combination of 22-oxa-1,25-dihydroxyvitamin D₃, a vitamin D₃ derivative, with vitamin K₂ (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cellsFUNATO, K; MIYAZAWA, K; YAGUCHI, M et al.Leukemia. 2002, Vol 16, Num 8, pp 1519-1527, issn 0887-6924Article

IgA-λ/IgG-κ biclonal myeloma in which two clones proliferated in individual sitesANDO, K; YAGUCHI, M; OKABE, S et al.Internal medicine (Tokyo. 1992). 2000, Vol 39, Num 2, pp 170-175, issn 0918-2918Article

A nonradioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activityOHYASHIKI, J. H; OHYASHIKI, K; TOYAMA, K et al.Trends in genetics (Regular ed.). 1996, Vol 12, Num 10, pp 395-396, issn 0168-9525Article

Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocolOHYASHIKI, J. H; OHYASHIKI, K; SANO, T et al.Japanese journal of cancer research. 1996, Vol 87, Num 4, pp 329-331, issn 0910-5050Article

Do leukemia patients with chromosome 16 inversion-inv (16) (p13q22) ― Have a rare fragile site at 16q22?OHYASHIKI, K; OHYASHIKI, J. H; TOYAMA, K et al.Cancer genetics and cytogenetics. 1988, Vol 31, Num 1, pp 31-34, issn 0165-4608Article

Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infectionZHANG, Y; OHYASHIKI, J. H; TAKAKU, T et al.British journal of cancer. 2006, Vol 94, Num 4, pp 599-608, issn 0007-0920, 10 p.Article

A sole del(15q) anomaly in post-myelodysplasia acute myeloid leukemiaYAHATA, N; OHYASHIKI, K; IWASE, O et al.Leukemia research. 1998, Vol 22, Num 9, pp 845-847, issn 0145-2126Article

Translocation t(3;4)(q26;q21) in myelodysplastic syndrome with megakaryoblastic proliferationOHYASHIKI, K; ENOMOTO, Y; WATANABE, Y et al.Cancer genetics and cytogenetics. 1988, Vol 34, Num 1, pp 5-9, issn 0165-4608Article

Variant t(8;18;21) translocation in acute myeloid leukemiaUCHIDA, H; OHYASHIKI, K; TOYAMA, K et al.Cancer genetics and cytogenetics. 1988, Vol 36, Num 2, pp 231-232, issn 0165-4608Article

Secondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosisOHYASHIKI, K; KOCOVA, M; RYAN, D. H et al.Cancer genetics and cytogenetics. 1986, Vol 19, Num 3-4, pp 331-333, issn 0165-4608Article